• Boston Pharmaceuticals signs three-year agreement with GSK pharmaceutical-business-review
    March 19, 2021
    The US-based clinical stage biopharmaceutical company Boston Pharmaceuticals has announced the signing of a unique three-year out-license and option agreement with the UK-based GlaxoSmithKline (GSK).
PharmaSources Customer Service